探讨脑脉康方治疗脑动脉硬化症的临床观察
杨 阳
（日照市人民医院，山东 日照，276800）
中图分类号：R255.2 文献标识码：A 文章编号：1674-7860（2016）18-0054-02 证型：BDG
【摘 要】目的：探究脑动脉硬化症的临床诊治中，采用脑脉康方药物进行诊治，观察其临床应用效果。方法：选取2014年3月—2015年9月本院接受诊治的80例脑动脉硬化症患者作为研究的案例，根据随机数字表法，将其划分为探究组和比较组，每组40例，比较组患者给予镇脑宁药物治疗，探究组患者给予脑脉康方药物进行诊治，对比两组患者疗效。结果：探究组患者给予脑脉康方药物进行诊治后，其疾病治疗的总有效率高达95.0%；比较组患者给予镇脑宁药物治疗后，其疾病治疗的总有效率达到85.0%。同时在中医证候积分方面，探究组患者相较于比较组患者，有显著差异，具有统计学意义（P＜0.05）。结论：在脑动脉硬化症的临床诊治中，采用脑脉康方药物进行诊治，具有良好的治疗效果，不仅能有效地提升疾病治疗总有效率，还能有效地缓解患者的中医证候，改善患者的身心健康状况。
【关键词】脑脉康方；脑动脉硬化症；临床观察
【Abstract】Objective:To explore the clinical diagnosis and treatment effect of Naomaikang treatmenin treating cerebral atherosclerosis. Methods: 80 patients with cerebral palsyatherosclerosis, admitted to our hospital from March 2014 to September 2015,were selected as research objects and randomLy divided into the observationgroup and the control group, with40 cases in each group. The control groupreceived Zhennaoning treatment while the observation group received Naomaikangtreatmen, efficacy of two groups were compared. Results:The total effective rate of the observation group was as high as95.0% after being given Naomaikang treatmen while that of the control group was85.0% after being given Zhennaoning treatment; the TCM syndrome score of theobservation group was better than that of the control group, the difference wasof statistical significance (P<0.05).Conclusion: Naomaikang treatmen had better therapeutic effect in clinicaldiagnosis and treatment of cerebral atherosclerosis; it could improve the totaleffective rate effectively in addition to relieving the patients’ TCM syndromeefficiently and improve the patients’ physical and mental health.
【Keywords】Naomaikang treatment; Cerebral artery sclerosis;Clinical observation
doi:10.3969/j.issn.1674-7860.2016.18.024
 |
